GlassScriptPhysician profile
Emran Riaz Imami
NPI 1215901848
$3,196.31
in general payments reported to CMS, 2019-2025
25 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $466 · 2020: $354 · 2021: $336 · 2022: $730 · 2023: $464 · 2024: $524 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,309.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $565.15 | 2020-2025 | Pifeltro, Dificid, Zerbaxa |
| Daiichi Sankyo INC. | $477.71 | 2020-2024 | Enhertu |
| Genentech USA, INC. | $245.28 | 2019-2020 | |
| Abbvie INC. | $184.19 | 2021-2022 | |
| Inari Medical, INC. | $177.94 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| W. L. Gore & Associates, INC. | $147.54 | 2019 | |
| Paratek Pharmaceuticals, INC. | $138.45 | 2023 | Nuzyra |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2024 | Abecma |
| Kci USA, INC. | $125.00 | 2019 | |
| Beigene USA, INC. | $125.00 | 2023 | Brukinsa |
| Harmony Biosciences LLC | $125.00 | 2024 | |
| Exelixis INC. | $123.19 | 2022 | |
| Puma Biotechnology, INC. | $123.19 | 2022 | |
| Hologic INC | $119.45 | 2020-2021 | |
| Seagen INC. | $101.60 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $78.97 | 2024 | |
| Theratechnologies INC. | $42.91 | 2024-2025 | Egrifta, Trogarzo |
| Allergan, INC. | $36.17 | 2019-2020 | |
| Leica Microsystems INC. | $28.59 | 2019-2021 | |
| Hologic Sales and Service, LLC | $25.83 | 2023 | Trunode, Localizer |
| Davol INC. | $22.83 | 2020 | |
| Medtronic Vascular, INC. | $16.56 | 2019 | |
| Janssen Biotech, INC. | $14.56 | 2023 | Symtuza |
| Boston Scientific Corporation | $13.25 | 2024 | Varithena Administration Pack |
| Galderma Laboratories, L.P. | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emran Imami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.